Filing Details

Accession Number:
0001225208-10-024902
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-15 17:39:48
Reporting Period:
2010-11-11
Filing Date:
2010-11-15
Accepted Time:
2010-11-15 17:39:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1051578 I E David Pyott One Edwards Way
Irvine CA 92614
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-11 20,000 $11.25 78,572 No 4 M Direct
Common Stock Acquisiton 2010-11-11 6,896 $11.60 85,468 No 4 M Direct
Common Stock Acquisiton 2010-11-11 6,068 $13.18 91,536 No 4 M Direct
Common Stock Acquisiton 2010-11-11 4,590 $17.43 96,126 No 4 M Direct
Common Stock Disposition 2010-11-11 7,126 $65.33 89,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option (Right to Acquire) Disposition 2010-11-11 20,000 $0.00 20,000 $11.25
Common Stock Director Stock Option (Right to Acquire) Disposition 2010-11-11 6,068 $0.00 6,068 $13.18
Common Stock Director Stock Option (Right to Acquire) Disposition 2010-11-11 6,896 $0.00 6,896 $11.60
Common Stock Director Stock Option (Right to Acquire) Disposition 2010-11-11 4,590 $0.00 4,590 $17.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2002-05-11 2011-05-11 No 4 M Direct
0 2001-07-01 2011-07-01 No 4 M Direct
0 2002-07-01 2012-06-30 No 4 M Direct
0 2004-07-01 2011-06-30 No 4 M Direct
Footnotes
  1. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  2. This transaction was executed in multiple trades at prices ranging from $65.20 to $65.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.